Question

I am a breastfeeding mother and i want to know if it is safe to use BRN 0759557? Is BRN 0759557 safe for nursing mother and child? Does BRN 0759557 extracts into breast milk? Does BRN 0759557 has any long term or short term side effects on infants? Can BRN 0759557 influence milk supply or can BRN 0759557 decrease milk supply in lactating mothers?

BRN 0759557 lactation summary

BRN 0759557 usage has low risk in breastfeeding
  • DrLact safety Score for BRN 0759557 is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of BRN 0759557 may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that BRN 0759557 may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of BRN 0759557 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using BRN 0759557 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About BRN 0759557 usage in lactation

Intermediate-acting Benzodiazepine. Excreted in low levels into breast milk. No adverse effect on breastfed infant has been reported. However, some cases of high infant serum levels along with excessive somnolence and respiratory pauses when the mother started treatment at pregnancy were reported. Avoid use in preterm infants and early neonatal period. Whether anxiolytic rather than anticonvulsivant treatment is intended, benzodiazepines with a shorter half-life span like Lorazepam or Oxazepam should be considered. Eventual and low dose use of benzodiacepines are compatible with breastfeeding. Use the short-acting benzodiazepine and minimal effective dose as possible mostly in the neonatal period. WHO Model List of Essential Medicines (2002) rates it compatible with breastfeeding. Follow-up for sedation and feeding ability of the infant. Bed-sharing is not recommended for mothers who are taking this medication.

Answer by DrLact: About BRN 0759557 usage in lactation

Maternal BRN 0759557 occasionally causes sedation in their breastfed infants, especially when given with other central nervous system depressants. Monitor the infant for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of psychotropic drugs. Monitoring of the infant's serum concentration may be indicated if excessive sedation occurs. Because it has a long half-life, a safer, shorter-acting drug should be used as rather than BRN 0759557.[1][2] An expert consensus guideline indicates that low-dose BRN 0759557 is an acceptable choice for refractory restless leg syndrome during lactation.[3]

BRN 0759557 Side Effects in Breastfeeding

Excessive periodic breathing and prolonged apnea and cyanosis occurred in a newborn at 6 hours after birth at 36 weeks gestation and reoccurred repeatedly up to 10 days of age. The neonate was breastfed starting at 72 hours after delivery and her mother took BRN 0759557 (dose not stated) during pregnancy and lactation. The repeated periodic breathing episodes continued up to 10 weeks of age and were possibly related to BRN 0759557 in breastmilk. A neurodevelopmental examination was normal at 5 months of age.[5] The infant of a mother taking BRN 0759557 1 mg daily during pregnancy and lactation was rated as highly apathetic and had decreased weight increase and slight neurologic signs at 4 weeks of age, but normal intelligence at 6 years of age.[9] None of 11 infants whose mothers were taking BRN 0759557 in dosages ranging from 0.25 to 2 mg daily (including 4 who were taking other psychotropic drugs also) had any side effects reported by their mothers. The infants' average age was 7.9 weeks, but 6 were under 1 month of age.[8] One author reported a mother who was taking BRN 0759557 6 mg daily and carbamazepine 1400 mg daily. The infant had serum BRN 0759557 levels of about 40% of the mother's serum level. Her infant was described as "somewhat lazy at the breast and tired."[7] In a telephone follow-up study, 124 mothers who took a benzodiazepine while nursing reported whether their infants had any signs of sedation. Twenty-two mothers took BRN 0759557 while breastfeeding and 1 reported sedation in her infant. She was taking BRN 0759557 0.25 mg twice daily, flurazepam 15 mg daily, 1 mg of bupropion daily, and 0.75 mg of risperidone daily.[10] All adverse reactions in breastfed infants reported in France between January 1985 and June 2011 were compiled by a French pharmacovigilance center. Of 174 reports, BRN 0759557 was reported to cause adverse reactions in 5 infants and to be one of the drugs most often suspected in serious adverse reactions, primarily sedation. One two-month old infant had well-documented hypotonia, somnolence and apnea caused by BRN 0759557 in breastmilk.[11]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.